AUTOLOGOUS STEM CELL TRANSPLANTATION AND IMMUNOMODULATION IN AMYOTROPHIC LATERAL SCLEROSIS
Background: Amyotrophic lateral sclerosis (ALS) is a rare chronic degenerative disease. The only approved treatment, Riluzole, is not available and is not economically affordable for most patients. Objective: To report here a case of a pregnant woman 27 years of age with ALS, confirmed through el...
Guardado en:
Autores principales: | David Uriel Ayllón Álvarez, Mariana Neri Calixto, César Humberto Aparicio Albarrán, Hugo Mendieta Zerón |
---|---|
Formato: | article |
Lenguaje: | EN ID |
Publicado: |
University of Brawijaya
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a0b0fe17bec94c87a977d434461622a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amyotrophic lateral sclerosis official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
Publicado: (2006) -
Amyotrophic lateral sclerosis and frontotemporal degeneration
Publicado: (2000) -
Amyotrophic lateral sclerosis and other motor neuron disorders official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
Publicado: (2005) -
A Platform to Understand Amyotrophic Lateral Sclerosis (ALS) and Extend Human Motor Neurons Longevity
por: Cáceres,D. E, et al.
Publicado: (2019) -
γ' Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis
por: Ana Catarina Pronto-Laborinho, et al.
Publicado: (2021)